Combilytics
London
About Combilytics
Combilytics is a biotechnology company focused on creating anti-aging products. It's products include EternLFX, which is a breakthrough natural senolytic formula designed to clear senescent cells from bodies, increasing health span and potentially lifespan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2022)
- Website: combilytics.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Personal Health, Wellness
Social Profiles
Canonical: https://fsome.com/organization/combilytics-180700 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.